Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
16936897
DOI
10.5507/bp.2006.001
Knihovny.cz E-zdroje
- MeSH
- alkaloidy farmakologie MeSH
- apoptóza účinky léků MeSH
- benzofenantridiny farmakologie MeSH
- buněčné linie MeSH
- buněčný cyklus účinky léků MeSH
- isochinoliny farmakologie MeSH
- lidé MeSH
- protinádorové látky farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- alkaloidy MeSH
- benzofenantridiny MeSH
- chelerythrine MeSH Prohlížeč
- isochinoliny MeSH
- protinádorové látky MeSH
- sanguinarine MeSH Prohlížeč
OBJECTIVES: This review summarizes the involvement of sanguinarine and chelerythrine in cell cycle regulation and cell death in various cell lines. It is focused on their potential in the treatment of cancer. METHODS: We conducted a search of PubMed, ScienceDirect and Medline for papers on the molecular mechanisms of the biological activity of sanguinarine and chelerythrine published mainly from 1995 to 2006. RESULTS AND CONCLUSIONS: Our analysis of the published studies suggested that these alkaloids are not only good candidates for chemotherapeutic regimens but may also contribute to the development of successful immune therapies of some carcinomas due to their apoptotic potential. However, the complete signalling cascade in which sanguinarine and chelerythrine treatment induces apoptotic cell death is not yet understood. Overall, the results of recent studies suggest that sanguinarine and chelerythrine may be useful as agents in the management of cancer.
Citace poskytuje Crossref.org